ANGOのチャート
ANGOの企業情報
symbol | ANGO |
---|---|
会社名 | AngioDynamics Inc (アンジオダイナミクス) |
分野(sector) | Health Care ヘルスケア |
産業(industry) | Medical/Dental Instruments |
業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連(Health Care) |
概要 | 事業概要 アンジオダイナミクス(AngioDynamics Inc.)は血管アクセス、末梢血管疾患の治療、腫瘍学および外科手術環境での使用のために、専門の医療提供者によって使用される医療、外科と診断装置を設計、製造および販売する。同社のデバイスは低侵襲イメージガイド付きの手順に使用される。同社は、末梢血管、血管アクセスおよび腫瘍・外科の3つの製品グルーピング製品を提供する。同社の末梢血管製品には、流体管理、静脈、血栓管理等の主要製品が含まれる。同社のBioFlo製品は、Endexo技術を血管アクセス製品の製造・設計に組み込む。同社の腫瘍・外科製品にはマイクロ波アブレーション製品、ラジオ波アブレーション(RFA)、NanoKnife製品ラインなどを含む。 アンジオダイナミクスは米国の医療機器メ―カ―。末梢血管疾患の治療や手術に使用される医療機器の開発、製造、販売を行う。同社の製品は高周波焼灼術用機器、NanoKnifeの他、血管アクセス製品、血管造影製品、透析製品、血管形成術製品、排水製品、血栓溶解製品、塞栓製品、静脈製品や腎臓治療の製品など。本社はニューヨーク州レ―サム。 |
本社所在地 | 14 Plaza Drive Latham NY 12110 USA |
代表者氏名 | Howard W. Donnelly ハワード・W・ドネリー |
代表者役職名 | Independent Chairman of the Board |
電話番号 | +1 518-798-1215 |
設立年月日 | 1988年 |
市場名 | NASDAQ National Market System |
ipoyear | 2004年 |
従業員数 | 1145人 |
url | www.angiodynamics.com |
nasdaq_url | https://www.nasdaq.com/symbol/ango |
adr_tso | ― |
EBITDA | EBITDA(百万ドル) 50.57800 |
終値(lastsale) | 20.455 |
時価総額(marketcap) | 759322900.74 |
時価総額 | 時価総額(百万ドル) 755.42510 |
売上高 | 売上高(百万ドル) 344.21400 |
企業価値(EV) | 企業価値(EV)(百万ドル) 819.75710 |
当期純利益 | 当期純利益(百万ドル) 8.50100 |
決算概要 | 決算概要 BRIEF: For the three months ended 31 August 2018 AngioDynamics Inc. revenues decreased less than 1% to $85.3M. Net loss increased from $35K to $469K. Revenues reflect Vascular Access segment increase of 2% to $23.8M Peripheral Vascular segment increase of less than 1% to $50M International segment increase of 7% to $17.7M also reflect Oncology/Surgery segment decrease of 6% to $11.6M United States segment decrease of 2% to $67.7M. |
ANGOのテクニカル分析
ANGOのニュース
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call 2021/01/08 15:15:25 AlphaStreet
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief Financial Analysts: Jayson T. Bedford — Raymond […]
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript 2021/01/07 14:58:38 AlphaStreet
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Presentation: Operator Good morning, and welcome to the AngioDynamics Fiscal Year 2021 Second Quarter Earnings Call. [Operator Instructions] […]
AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results 2021/01/07 12:00:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the second quarter of fiscal year 2021, which ended November 30, 2020. “I am very pleased with our performance in the second quarter, as sales execution and continued expense management drove strong revenue and positive earnings,” commented Jim Clemmer, Preside
AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference 2021/01/04 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference at 2:50 p.m. ET on Thursday, January 14, 2021. A live webcast of the prese
AngioDynamics to Present at the Needham Virtual Growth Conference 2020/12/29 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 23rd Annual Needham Virtual Growth Conference at 1:15 p.m. ET on Monday, January 11, 2021. A live webcast of the presentation wi
AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference 2021/01/04 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference at 2:50 p.m. ET on Thursday, January 14, 2021. A live webcast of the prese
AngioDynamics to Present at the Needham Virtual Growth Conference 2020/12/29 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 23rd Annual Needham Virtual Growth Conference at 1:15 p.m. ET on Monday, January 11, 2021. A live webcast of the presentation wi
Global Angioplasty Balloons Market (2020 to 2025) - Increasing Preference for Minimally Invasive Procedures is Driving Growth - ResearchAndMarkets.com 2020/12/28 13:02:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Angioplasty Balloons Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The rise in the geriatric population could result in an exponential increase in Coronary heart disease prevalence, which, in turn, is propelling the angioplasty balloons market. Companies Mentioned Abbot Laboratories AngioDynamics BIOTRONIK Boston Scientific Corporation Cook Medical Cordis (Cardinal Health) Medtronic Merit Medical S
Catheters Market 2020 Analysis by Manufacturers – Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Coloplast A/S, Cook Incorporated, Flexicath Ltd 2020/12/14 07:00:18 OpenPR
Catheters market report is a blend of statistical figures, facts and data that are derived out of extensive research by a bunch of professional analysts. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and
AngioDynamics to Report Fiscal 2021 Second Quarter Financial Results on January 7, 2021 2020/12/09 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2021 before the market open on Thursday, January 7, 2021. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results. To participate in the conference call, dial
AngioDynamics to Present at the Needham Virtual Growth Conference 2020/12/29 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 23rd Annual Needham Virtual Growth Conference at 1:15 p.m. ET on Monday, January 11, 2021. A live webcast of the presentation wi
Global Angioplasty Balloons Market (2020 to 2025) - Increasing Preference for Minimally Invasive Procedures is Driving Growth - ResearchAndMarkets.com 2020/12/28 13:02:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Angioplasty Balloons Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The rise in the geriatric population could result in an exponential increase in Coronary heart disease prevalence, which, in turn, is propelling the angioplasty balloons market. Companies Mentioned Abbot Laboratories AngioDynamics BIOTRONIK Boston Scientific Corporation Cook Medical Cordis (Cardinal Health) Medtronic Merit Medical S
Catheters Market 2020 Analysis by Manufacturers – Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Coloplast A/S, Cook Incorporated, Flexicath Ltd 2020/12/14 07:00:18 OpenPR
Catheters market report is a blend of statistical figures, facts and data that are derived out of extensive research by a bunch of professional analysts. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and
AngioDynamics to Report Fiscal 2021 Second Quarter Financial Results on January 7, 2021 2020/12/09 21:01:00 Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2021 before the market open on Thursday, January 7, 2021. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results. To participate in the conference call, dial
Wolff Parkinson White Syndrome Market 2020: Know Factors Driving The Market To Record Growth To 2026 | Top Players- GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., AngioDynamics 2020/12/03 17:11:29 OpenPR
An influential Wolff Parkinson White Syndrome Market report carries out an evaluation of the growth rate and the market value of Wolff Parkinson White Syndrome industry based on market dynamics and growth inducing factors. Thorough market analysis covered in this